Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.78 Analyst target: $10.00 Upside: 461.80%
Black Diamond Therapeutics, Inc., a biotechnology company, discovers and develops small molecule tumor agnostic therapies. The company is headquartered in Cambridge, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.